186 related articles for article (PubMed ID: 1663589)
21. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
Tang KM; Jang EK; Haslam RJ
Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
[TBL] [Abstract][Full Text] [Related]
22. Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.
Anderson R; Goolam Mahomed A; Theron AJ; Ramafi G; Feldman C
Br J Pharmacol; 1998 Jun; 124(3):547-55. PubMed ID: 9647480
[TBL] [Abstract][Full Text] [Related]
23. Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles.
Muller B; Stoclet JC; Lugnier C
Eur J Pharmacol; 1992 Mar; 225(3):263-72. PubMed ID: 1325367
[TBL] [Abstract][Full Text] [Related]
24. Cyclic 3',5'-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells.
Yamaki M; McIntyre S; Rassier ME; Schwartz JH; Dousa TP
Am J Physiol; 1992 Jun; 262(6 Pt 2):F957-64. PubMed ID: 1320333
[TBL] [Abstract][Full Text] [Related]
25. Preliminary identification and role of phosphodiesterase isozymes in human basophils.
Peachell PT; Undem BJ; Schleimer RP; MacGlashan DW; Lichtenstein LM; Cieslinski LB; Torphy TJ
J Immunol; 1992 Apr; 148(8):2503-10. PubMed ID: 1373172
[TBL] [Abstract][Full Text] [Related]
26. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
27. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
[TBL] [Abstract][Full Text] [Related]
28. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst.
Nielson CP; Vestal RE; Sturm RJ; Heaslip R
J Allergy Clin Immunol; 1990 Nov; 86(5):801-8. PubMed ID: 1977788
[TBL] [Abstract][Full Text] [Related]
29. Involvement of calcium in the thimerosal-stimulated formation of leukotriene by fMLP in human polymorphonuclear leukocytes.
Hatzelmann A; Haurand M; Ullrich V
Biochem Pharmacol; 1990 Feb; 39(3):559-67. PubMed ID: 2154987
[TBL] [Abstract][Full Text] [Related]
30. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.
Torphy TJ; Undem BJ; Cieslinski LB; Luttmann MA; Reeves ML; Hay DW
J Pharmacol Exp Ther; 1993 Jun; 265(3):1213-23. PubMed ID: 8389856
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
34. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
Shahid M; Nicholson CD
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
[TBL] [Abstract][Full Text] [Related]
35. Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
Schudt C; Winder S; Eltze M; Kilian U; Beume R
Agents Actions Suppl; 1991; 34():379-402. PubMed ID: 1665311
[TBL] [Abstract][Full Text] [Related]
36. Attenuation by phosphodiesterase inhibitors of lipopolysaccharide-induced thromboxane release and bronchoconstriction in rat lungs.
Uhlig S; Featherstone RL; Held HD; Nüsing R; Schudt C; Wendel A
J Pharmacol Exp Ther; 1997 Dec; 283(3):1453-9. PubMed ID: 9400021
[TBL] [Abstract][Full Text] [Related]
37. Zardaverine as a selective inhibitor of phosphodiesterase isozymes.
Schudt C; Winder S; Müller B; Ukena D
Biochem Pharmacol; 1991 Jun; 42(1):153-62. PubMed ID: 1648920
[TBL] [Abstract][Full Text] [Related]
38. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
[TBL] [Abstract][Full Text] [Related]
39. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
40. Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils.
Flamand N; Surette ME; Picard S; Bourgoin S; Borgeat P
Mol Pharmacol; 2002 Aug; 62(2):250-6. PubMed ID: 12130675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
